Novavax, Inc. Share Price
NVAXNovavax, Inc. Stock Performance
Open $8.09 | Prev. Close $8.23 | Circuit Range N/A |
Day Range $8.06 - $8.29 | Year Range $6.21 - $11.96 | Volume 1,56,785 |
Average Traded $8.18 |
Novavax, Inc. Share Price Chart
About Novavax, Inc.
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Novavax, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
17-Jul-26 | $8.09 | $8.21 | -0.36% |
16-Jul-26 | $8.27 | $8.24 | -2.20% |
15-Jul-26 | $8.39 | $8.43 | -0.06% |
14-Jul-26 | $8.88 | $8.43 | -5.39% |
13-Jul-26 | $9.08 | $8.91 | -4.71% |
10-Jul-26 | $9.37 | $9.35 | -0.48% |
09-Jul-26 | $9.45 | $9.39 | +0.37% |